China's First PMTA Non-Clinical Lab by Feelm Analysis Center

Recently, it has been reported that the Analytical Testing and Safety Assessment Center (referred to as the "Safety Assessment Center") of Smoler has established China's first PMTA (pre-market tobacco application) comprehensive non-clinical testing laboratory. The laboratory currently covers PMTA non-clinical research requirements, including material safety, harmful and potentially harmful constituents (HPHCs) and toxicity testing.

This is the first PMTA testing laboratory established domestically, which will assist the global leading provider of closed-system electronic cigarette solutions, Smoore, and its flagship brand FEELM, in further improving product safety and helping partner brands successfully pass PMTA certification.

The only laboratory in China that covers all substances in HPHCs.

Before this, electronic cigarette companies that wanted to enter the international market had to rely on third-party partners to complete PMTA testing, which was expensive and time-consuming. With the establishment of a new domestic laboratory, FEELM's brand partners can more easily undergo PMTA certification, increasing their chances of entering the international market.

Dr. Long, the director of the Smyrna Evaluation Center, has revealed that the FDA has placed significant emphasis on HPHCs and has identified a list of 33 substances to be tested. The Smyrna Evaluation Center is currently capable of testing 37 substances and is the only laboratory in the country that has the ability to test all substances included in the list of HPHCs.

The laboratory conducted tests using the world-leading HPHCs (harmful and potentially harmful constituents) database developed by Philip Morris International, which is based on multiple authoritative international toxicity databases. In addition, the lab incorporated advanced computational toxicology software to predict unidentified and potential harmful constituents not included in the database, further enhancing Philip Morris's safety assessment capabilities.

Assist brand clients in entering the overseas market.

Since the establishment of its first basic research institute in 2017, Simoer has been continuously expanding its global leading detection projects and building a comprehensive product safety verification system. Currently, Simoer's safety evaluation center has established the industry's first E&L (extractables and leachables) analysis testing laboratory, raising the material safety standard for electronic atomization to medical grade, and recently completed a toxicity testing laboratory that is now open to FEELM customers.

Smol intends to become the driving force behind electronic cigarette brands approaching the FDA and other regulatory agencies, allowing the brand to enter a broader overseas market. To date, eight of their products have been approved by the FDA for market release, with several produced by Smol, indicating FDA recognition of the processes and testing mechanisms in their new laboratory in China. Concurrently, Smol is collaborating with brand partners and FEELM customers to expand their testing scope and provide stronger support for product design, while also preparing to release safety reports.

This article contains excerpts or reprints from third-party sources, and their copyright belongs to the original media and authors. If there is any infringement, please contact us for deletion. Any organization or individual who wants to reprint must contact the author and should not directly reprint.